StockCIK 946644

AIM ImmunoTech Inc. (AIM): Insider Trades and Fund Holdings

In the past 12 months, AIM ImmunoTech Inc. insiders reported 6 open-market purchases worth $24K and 0 sales worth $0.

6Insider buys, 12 months

$24KBought by insiders, 12 months

$0Sold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 26, 2026.

Recent AIM insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 26	Oct 23	Thomas K. EquelsCEO	CEO	▲ BUY	31,675	0.16	$5K	+20%	Form 4 ↗
Oct 23	Oct 22	Thomas K. EquelsCEO	CEO	▲ BUY	31,250	0.163	$5K	+25%	Form 4 ↗
Sep 18	Sep 17	Thomas K. EquelsCEO	CEO	▲ BUY	24,000	0.208	$5K	+23%	Form 4 ↗
Sep 17	Sep 16	Thomas K. EquelsCEO	CEO	▲ BUY	11,000	0.21	$2K	+12%	Form 4 ↗
Sep 16	Sep 15	Thomas K. EquelsCEO	CEO	▲ BUY	22,000	0.221	$5K	+32%	Form 4 ↗
Sep 15	Sep 14	Thomas K. EquelsCEO	CEO	▲ BUY	5,900	0.219	$1K	+9.2%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Thomas K. Equels	CEO	6	$24K	0	$0	Oct 26, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →